Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;90(2):257-65.
doi: 10.1038/labinvest.2009.129. Epub 2009 Dec 7.

The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury

Kun Wang  1 , Ivan Damjanov, Yu-Jui Yvonne Wan
Affiliations

The protective role of pregnane X receptor in lipopolysaccharide/D-galactosamine-induced acute liver injury

Kun Wang et al. Lab Invest. 2010 Feb.

Abstract

The pregnane X receptor (PXR) is a nuclear receptor transcription factor regulating drug-metabolizing enzymes and transporters that facilitate xenobiotic and endobiotic detoxification. Recent studies show that PXR is important in abrogating intestinal tissue damage. This study examines the role of PXR in lipopolysaccharide (LPS)/D-galactosamine (GalN)-induced acute liver injury using wild-type and PXR-null mice. LPS/GalN-treated PXR-null mice had greater increases of alanine transaminase (ALT), hepatocyte apoptosis, necrosis, and hemorrhagic liver injury than wild-type mice. LPS/GalN-mediated phosphorylation of JNK1/2 and ERK1/2 was differentially regulated in wild-type and PXR-null mice. Importantly, LPS/GalN-induced hepatic Stat3 survival signaling was impaired and early activation of Jak2 was delayed in PXR-null mice. Expression levels of pro-survival proteins Bcl-xL and heme oxygenase-1 (HO-1), which are downstream of Stat3, were substantially lower in PXR-null than wild-type mouse livers after LPS/GalN treatment. Autophagy is also involved in LPS/GalN-induced liver injury. Lack of PXR resulted in a significant reduction of LC3B-I, -II as well as Beclin-1 protein levels after LPS/GalN treatment. In addition, PXR is implicated in hepatocytes homeostasis. Taken together, PXR is a critical hepatoprotective factor. Increases of LPS/GalN-induced hepatocyte apoptosis and liver injury in PXR-null mice are due to deregulated mitogen-activated protein (MAP) kinase activation as well as delayed Jak2/Stat3 activation, which lead to a compromise in defense mechanisms that involve Bcl-xL-, HO-1, and autophagy-mediated pathways.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PXR-null mice are sensitive to LPS/GalN-induced liver injury. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (A) ALT levels. Data represent means ± SD. (n=5/group/time point). (B) Representative H&E-stained liver sections of wild type and PXR-null mice 5 h post LPS/GalN injection. Sporadically, apoptotic hepatocytes (triangle) and neutrophil infiltrations (arrow) were observed in liver sections of saline-treated PXR-null mice. * P < 0.05, compared with wild type mice of 0 h; # P < 0.05, compared within same time point.
Figure 2
Figure 2
Phosphorylation of hepatic MAP kinases is differentially altered by LPS/GalN in wild type and PXR-null mice. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (n=5/group/time point). Livers were removed at the time point as indicated. Liver proteins were immunoblotted with indicated antibodies and representative samples are shown in the figure.
Figure 3
Figure 3
Activation of Stat3 by LPS/GalN is delayed in the livers of PXR-null mice. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (n=5/group/time point). Livers were removed at the time point as indicated. Liver proteins were immunoblotted with indicated antibodies and representative samples are shown in the figure.
Figure 4
Figure 4
Loss of PXR impairs LPS/GalN-induced activation of Jak2 in the livers of PXR-null mice. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (n=5/group/time point). Livers were removed at the time point as indicated. Hepatic cytosal fractions were immunoblotted with indicated antibodies. Representative samples are shown in the figure.
Figure 5
Figure 5
LPS/GalN-induced activation of p65 is augmented in the livers of PXR-null mice. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (n=5/group/time point). Livers were removed at the time point as indicated. Liver proteins were immunoblotted with indicated antibody and representative samples are shown in the figure.
Figure 6
Figure 6
LPS/GalN-induced hepatocyte apoptosis is augmented in PXR-null mice. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (n=5/group/time point). (A) Representative TUNEL staining of liver sections of wild type and PXR-null mice i.p. injected with LPS/GalN or saline for 5 h. (B) Quantification of TUNEL-positive hepatocytes of liver sections of wild type or PXR-null mice 5 h post LPS/GalN injection. * P < 0.05, compared with wild type mice of 0 h; # P < 0.05, compared within same time point. (C) Immunoblot analysis of cleaved caspase-3. Representative samples are shown in the figure.
Figure 7
Figure 7
Loss of PXR decreases the levels of anti-apoptotic proteins and alters the expression of proteins involved in autophagy pathways after LPS/GalN injection. Mice were i.p. injected with LPS (100 μg/kg) and GalN (700 mg/kg) or saline. (n=5/group/time point). Livers were removed at the time point as indicated. Liver proteins were immunoblotted with indicated antibodies. Representative samples are shown in the figure.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45–65. - PubMed
    1. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3(3):221–227. - PubMed
    1. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature. 1995;376(6536):167–170. - PubMed
    1. Streetz KL, Wustefeld T, Klein C, Kallen KJ, Tronche F, Betz UA, et al. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology. 2003;125(2):532–543. - PubMed
    1. Levy DE, Darnell JE., Jr. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3(9):651–662. - PubMed

Publication types